申请人:Takeda Chemical Industries, Ltd.
公开号:EP1219294A1
公开(公告)日:2002-07-03
A compound represented by the formula
wherein Ar1 and Ar2 are each an aromatic group optionally having substituents, P and Q are each a divalent aliphatic hydrocarbon group which optionally contains ether oxygen or ether sulfur in a carbon chain and which optionally has substituents, R1 and R3 are each (i) a hydrogen atom, (ii) an acyl group or (iii) an hydrocarbon group optionally having substituents, R2 and R4 are each (i) a hydrogen atom, (ii) an alkyl group optionally having substituents or (iii) an alkylcarbonyl optionally having substituents, R1 and R2 or R3 and R4 each optionally forms, together with the adjacent nitrogen atom, a monocyclic or fused nitrogen-containing heterocyclic group optionally having substituents, j is 0 or 1, a salt thereof or a prodrug thereof are useful as melanin-concentrating hormone antagonists.
一种由式表示的化合物
其中 Ar1 和 Ar2 分别是可选具有取代基的芳香基团,P 和 Q 分别是可选在碳链中含有醚氧或醚硫且可选具有取代基的二价脂肪族烃基,R1 和 R3 分别是 (i) 氢原子,(ii) 丙烯酸基团或 (iii) 可选具有取代基的烃基,R2 和 R4 分别是 (i) 氢原子,(ii) 可选具有取代基的烷基或 (iii) 可选具有取代基的烷基羰基,R1 和 R2 或 R3 和 R4 各自可选具有取代基的芳香基团、(R1和R2或R3和R4各自与相邻的氮原子一起形成单环或融合的含氮杂环基团,该杂环基团可选择具有取代基,j为0或1,其盐或原药可用作黑色素浓缩激素拮抗剂。